DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators
JAMA 1998; 279 (16) 1265-1272
We do not assume any responsibility for the contents of the web pages of other providers.